News Image

Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC's Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports

Provided By PR Newswire

Last update: Aug 15, 2022

Public-private partnership to enable the development of innovative, sustainable infrastructure designed to set the global standard for travel biosecurity

Read more at prnewswire.com

GINKGO BIOWORKS HOLDINGS INC

NYSE:DNA (7/31/2025, 3:45:50 PM)

13.04

+0.16 (+1.24%)



Find more stocks in the Stock Screener

Follow ChartMill for more